Risk Stratification for Cancer Patients During COVID-19


New patient levels for cancer programs are starting to increase after a significant drop, but their needs may be changing—and they may return at a volume that programs are not prepared for. Join Charles Saunders, MD, Chief Executive Officer, and Jennifer Webster, MS, Vice President of Analytics, IntegraConnect, as they present an overview of the current landscape of patient levels and services at cancer programs. They will provide guidance on effectively managing oncology business during and after the pandemic while maintaining a quality patient experience, and demonstrate how predictive analytics can show the impact COVID-19 may have on value-based care in the future.
View On-Demand Replay

This webcast is supported by educational grants from AstraZeneca Pharmaceuticals, Merck & Co., and Pfizer, Inc.